Keywords:
Molecular imaging, Nuclear medicine, Oncology, PET, PET-CT, Diagnostic procedure, Staging, Cancer
Authors:
A. Gaber, R. Núñez, E. Delpassand; HOUSTON, TX/US
DOI:
10.26044/ecr2021/C-10556
Results
All the images were of high quality. For subjects with a PSA less than 0.2 ng/ml the detection rate was 43%(3/7), with a PSA between 0.2 ng/ml to 0.5 ng/ml was 50%(9/18), with a PSA between 0.5 ng/ml to 1.0 ng/ml was 68.8%(11/16), with a PSA between 1.0 ng/ml to 2.0 ng/ml was 61.5%(8/13), with a PSA between 2.0 ng/ml to 5.0 ng/ml was 93.8%(15/16) and with a PSA of more than 5.0 ng/ml the detection rate was 100%(40/40). The average detection rate of 68Ga-PSMA-11 PET/ CT scan was 78.1% for the 110 patients. In comparison, 48.3% of patients had lesions detected by Pelvic MRI; 36.8% of patients had lesions detected by Chest /Abdomen/Pelvis CT, and 21.3% of patients had lesions detected on Bone Scintigraphy.
For all the subjects enrolled in the study, there were no SAE /AEs observed.